Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-31
1997-11-18
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548542, 548545, 548547, 554 43, 554 45, A61K 3140, C07C23578, C07D20746, C07D29524
Patent
active
056888252
ABSTRACT:
Disclosed is a method of inhibiting anandamide amidase in an individual or animal and novel inhibitors of anandamide amidase. The disclosed method and novel compounds can be used to reduce pain in an individual or animal suffering from pain, reducing nausea in an individual undergoing chemotherapy, for example cancer chemotherapy, suppressing appetite in an individual, reducing intraocular pressure in the eye of an individual or animal suffering from glaucoma and suppressing the immune system in an individual with an organ transplant.
REFERENCES:
patent: 3465024 (1969-09-01), Brownstein et al.
patent: 3577458 (1971-05-01), Brownstein et al.
Cherest, M., and Lusinchi, X., "The Action of Acetyl Chloride and of Acetic Anhydride on the Lithium Nitronate Salt of 2-Phenylnitroethane. Reactivity of the Intermediate Nitrile Oxide as an Electrophile or as a Dipole, Depending on the Nature of the Medium," Tetrahedron, 42 (14):3825-3840 (1986). (English Abstract). Derivatives with E-Azaaspidospermane Skeleton," Tetrahedron Letters, 30 (6) :719-722 (1989). (English Abstract).
Neunhoeffer, O. and Gottschlich, R., "Acylating Activity of O-Acylated Hydroxylamine Derivatives," Justus Liebigs Ann. Chem., 736:100-109 (1970). (English Abstract).
Cherest, M. and Lusinchi, X., "A Novel Electrophilic N-Amidation Via Electron Deficient Complexes: Action of Ferric Chloride on N-Acetyloxyamides." Tetrahedron Letters, 30 (6) :715-718 (1989).
Deutsch, D. G. and Chin, S. A., "Enzymatic Synthesis and Degradation of Anandamide, A Cannabinoid Receptor Agonist," Biochemical Pharmacology, 46(5) :791-796 (1993).
Smith, P. B., et al., "The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice," The Journal of Pharmacology and Experimental Therapeutics, 270 (1):219-227 (1994).
Horrevoets, A. J. G., et al., "Inactivation of Escherchia coli Outer-Membrane Phospholipase A by the Affinity Label Hexadecanesulfonyl Fluoride," Eur. J. Biochem., 198:247-253 (1991).
Kawase, M., et al., "Electrophilic Aromatic Substitution with N-Methoxy-N-acylnitrenium Ions Generated from N-Chloro-N-methoxyamides: Syntheses of Nitrogen Heterocyclic Compounds Bearing a N-Methoxyamide Group," J. Org. Chem., 54:3394-3403 (1989).
Koutek, B., et al., "Inhibitors of Arachidonoyl Ethanolamide Hydrolysis," The Journal of Biological Chemistry, 269 (37) :22937-22940 (1994).
Fride, E. and Mechoulam R., "Pharmacological Activity of the Cannabinoid Receptor Agonist, Anandamide, a Brain Constituent," European Journal of Pharmacology, 231:313-314 (1993).
Hill William Adam
Lin Sonyan
Makriyannis Alexandros
Owswecki Jane C.
Richter Johann
University of Connecticut
LandOfFree
Anandamide amidase inhibitors as analgesic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anandamide amidase inhibitors as analgesic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anandamide amidase inhibitors as analgesic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1566050